AEON Biopharma Sees 9.99% Stake by Nantahala Capital—What It Means for Investors
AEON Biopharma sees 9.99% stake by Nantahala Capital, but no control shift. Stock plummets from $1.45 highs to $0.15 lows—watch for future neurological breakthroughs.
2 minutes to read
